McDonald’s Exec Erlinger Sells $285K in Stock: SEC Filing by Mark Eisenberg 22.06.2024 "McDonald's USA President Joseph Erlinger sold $285k in company stock, signaling potential shifts in executive sentiment and company performance."
Esperion Stock Downgraded Amid Merck’s Competitive Pressure by Mark Eisenberg 20.06.2024 Esperion's stock downgraded by BofA due to rising competition from Merck's PCSK9 inhibitors. Analysts weigh in on efficacy and market ...
Coupang Director Sells $14.44M in Stock Amid Growth by Mark Eisenberg 18.06.2024 "Coupang Director Benjamin Sun sells $14.44M in stock, signaling optimism despite challenges. Q1 2024 shows 33% revenue rise, boosting investor ...
Alignment Healthcare Director Sells Shares, Ups Price Target by Mark Eisenberg 18.06.2024 "Jeffrey H. Margolis of Alignment Healthcare sells 1,200 shares worth $9,672. Despite insider sale, company sees 50% membership increase."
BofA Reiterates Buy on Zscaler, Sets $265 Target by Lilu Anderson 17.06.2024 BofA reaffirms Buy rating, $265 target for Zscaler post-Zenith Live 2024, citing strong innovations, strategic shifts, and positive market outlook.
Morgan Stanley Cuts RH Target Amid Economic Struggles by Mark Eisenberg 17.06.2024 The firm maintained its Buy rating despite highlighting a second-half sales increase as crucial to meet yearly targets amid a ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive News by Terry Bingman 15.06.2024 Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stock by Mark Eisenberg 15.06.2024 Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
Cellebrite Stock Upgraded by BofA: Buy Now! by Mark Eisenberg 16.02.2024 Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...
BofA Bets Big on Air Products: $264 Price Target by Mark Eisenberg 15.02.2024 BofA Securities upgrades Air Products to Buy, targets $264 price, citing positive reevaluation. The upgrade reflects confidence in the company's ...